Market News & Trends
Apricus Biosciences Files Marketing Application for Vitaros
Apricus Biosciences, Inc. recently announced its filing of a marketing application for Vitaros as a treatment for patients with erectile dysfunction (ED) in Switzerland, with…
Daiichi Sankyo Launches Direct Oral Factor Xa Inhibitor
Daiichi Sankyo Launches Direct Oral Factor Xa Inhibitor Daiichi Sankyo Company, Limited recently announced the launch of LIXIANA (JAN: Edoxaban Tosilate Hydrate, INN: edoxaban) in…
Hemispherx Biopharma Receives New Patent for Intranasal Ampligen
Hemispherx Biopharma, Inc. recently announced the granting of a new United States Patent for the use of Ampligen as a vaccine adjuvant for use with…
7/26/2011
Daiichi Sankyo Launches Direct Oral Factor Xa Inhibitor Daiichi Sankyo Company, Limited recently announced the launch of LIXIANA (JAN: Edoxaban Tosilate Hydrate, INN: edoxaban) in…
7/19/2011
Catalent & Sanwa Announce Exclusive License Agreement Catalent Pharma Solutions and Sanwa Kagaku Kenkyusho Co., Ltd. have recently entered into an exclusive agreement to bring…
Catalent & Sanwa Announce Exclusive License Agreement
Catalent Pharma Solutions and Sanwa Kagaku Kenkyusho Co., Ltd. have recently entered into an exclusive agreement to bring Sanwa's innovative drug delivery tableting technology to…
Generex Publishes Studies Confirming & Extending the Antigen Express Ii-Key Platform Technology
Generex Biotechnology Corporation recently announced the publication of studies conducted at the Mayo Clinic using the Antigen Express proprietary Ii-Key technology. Antigen Express, Inc., the…
Life Technologies Develops Potent Drug Delivery Technology for Therapeutics Market
Life Technologies corporation recently announced it has developed new drug delivery technology specially designed for therapeutic applications that is 100-fold more potent than previous formulations.…
Particle Sciences & Absorption Systems Form Relationship for Enhanced Services
Particle Sciences Inc. (PSI), a leading pharmaceutical CRO, and Absorption Systems, a leading provider of preclinical pharmacokinetic services, recently announced the two companies are working…
QRxPharma Announces NDA Filing
QRxPharma Limited recently announced initiation of the NDA approval process for MoxDuo IR with the US FDA. This NDA submission sets the stage for the…
Zogenix & DURECT Announce Agreement for Antipsychotic Product Candidate
Zogenix, Inc., a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain, and DURECT Corporation, a specialty pharmaceutical…
Evotec & Roche to Jointly Develop Biomarkers in Oncology
Evotec AG and Roche recently announced a collaboration in novel protein activity based biomarkers for Roche's oncology drugs under development. Evotec AG will employ its…
Gateway Analytical Registers With US FDA
Gateway Analytical showed confidence in its quality system, a collection of policies, procedures, plans, and supporting infrastructure documenting control over all activities, for pharmaceutical analysis…
Infinity Expands Development Program for Oral Smoothened Antagonist Targeting Hedgehog Pathway
Infinity Pharmaceuticals, Inc. recently announced it is expanding its clinical development program for IPI-926, a novel, oral small molecule that inhibits Smoothened, a key component…
ResearchDx & CompanDX Announce Strategic Partnership
ResearchDx, LLC recently announced a strategic partnership with CompanDX to offer a full capability to discover and deliver novel molecular diagnostic tests for clients in…
Unique Gel Capsule Structure Enables Co-Delivery of Different Types of Drugs
Researchers at the Georgia Institute of Technology have designed a multiple-compartment gel capsule that could be used to simultaneously deliver drugs of different types. The…
Zogenix Enters $30-Million Royalty Financing Agreement
Zogenix, Inc., a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain, recently announced it has entered into…
7/12/2011
Evotec & Roche to Jointly Develop Biomarkers in Oncology Evotec AG and Roche recently announced a collaboration in novel protein activity based biomarkers for…
Alliqua Expands Patent Portfolio for Transdermal Drug Delivery Platform
Alliqua, Inc, an advanced biomedical products company focused on the development and manufacturing of proprietary drug delivery and liver health technologies, recently announced it has…
Evonik Degussa Provides Pharmaceutical Melt Extrusion Technology Services
Evonik Degussa Corporation recently announced the purchase of a Leistritz Nano 16-mm (TSE) Twin Screw Extruder to serve the growing number of customers using pharmaceutical…
